Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly activ… Read more
Market Cap & Net Worth: Zhejiang Tailin Bioengineering Co Ltd (300813)
Zhejiang Tailin Bioengineering Co Ltd (SHE:300813) has a market capitalization of $448.80 Million (CN¥3.29 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #15764 globally and #4200 in its home market, demonstrating a 3.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Tailin Bioengineering Co Ltd's stock price CN¥27.17 by its total outstanding shares 121199219 (121.20 Million).
Zhejiang Tailin Bioengineering Co Ltd Market Cap History: 2020 to 2026
Zhejiang Tailin Bioengineering Co Ltd's market capitalization history from 2020 to 2026. Data shows growth from $379.51 Million to $448.80 Million (13.76% CAGR).
Zhejiang Tailin Bioengineering Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.82x
Zhejiang Tailin Bioengineering Co Ltd's market cap is 0.82 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
21.86x
Zhejiang Tailin Bioengineering Co Ltd's market cap is 21.86 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $379.51 Million | $200.24 Million | $48.39 Million | 1.90x | 7.84x |
| 2021 | $776.28 Million | $283.25 Million | $63.53 Million | 2.74x | 12.22x |
| 2022 | $581.12 Million | $373.88 Million | $79.69 Million | 1.55x | 7.29x |
| 2023 | $403.04 Million | $269.86 Million | $19.67 Million | 1.49x | 20.49x |
| 2024 | $285.27 Million | $349.00 Million | $13.05 Million | 0.82x | 21.86x |
Competitor Companies of 300813 by Market Capitalization
Companies near Zhejiang Tailin Bioengineering Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Zhejiang Tailin Bioengineering Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Zhejiang Tailin Bioengineering Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Zhejiang Tailin Bioengineering Co Ltd's market cap moved from $379.51 Million to $ 448.80 Million, with a yearly change of 13.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥448.80 Million | +10.58% |
| 2025 | CN¥405.86 Million | +42.27% |
| 2024 | CN¥285.27 Million | -29.22% |
| 2023 | CN¥403.04 Million | -30.64% |
| 2022 | CN¥581.12 Million | -25.14% |
| 2021 | CN¥776.28 Million | +104.55% |
| 2020 | CN¥379.51 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Zhejiang Tailin Bioengineering Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $448.80 Million USD |
| MoneyControl | $448.80 Million USD |
| MarketWatch | $448.80 Million USD |
| marketcap.company | $448.80 Million USD |
| Reuters | $448.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.